OrthoPediatrics Corp.
Financials
Valuation Metrics
OrthoPediatrics Corp.'s Market Cap is $782M. At end of 2025 it was $419M. Ranked #2643 of 3,114 in US market (top 85%), #1132 of 1,469 on NASDAQ (top 77%), #166 of 203 in Health Care Equipment & Services (top 82%) by Market Cap.
Investment Metrics(as of 2026-11-02)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | $782M | US#2,643/3,114 Sec#166/203 |
| Revenue | $264M | US#2,489/3,114 Sec#163/203 |
| Net Income | $-34M | US—/3,114 Sec—/203 |
| Total Assets | $509M | US#2,754/3,114 Sec#157/203 |
| Net Assets | $339M | US#2,454/3,114 Sec#137/203 |
| Employees | 602 | US#2,187/3,114 Sec#155/203 |
| Value | ||
| P/B | 2.30x | US#1,167/3,114 Sec#49/203 |
| P/S | 2.96x | US#1,503/3,114 Sec#105/203 |
| EV/EBITDA | 354.63x | US—/3,114 Sec—/203 |
| FCF Yield | 0.41% | US—/3,114 Sec—/203 |
| Profitability | ||
| ROE | -9.98% | US#2,381/3,114 Sec#138/203 |
| ROA | -6.66% | US#2,607/3,114 Sec#151/203 |
| Op. Margin | -8.38% | US#2,512/3,114 Sec#156/203 |
| Revenue Growth | 16.15% | US#927/3,114 Sec#65/203 |
| Financial Health | ||
| Debt Ratio | 50.02% | US#551/3,114 Sec#63/203 |
| Total Debt | $98M | US#2,465/3,114 Sec#140/203 |
| FCF | $3M | US#2,330/3,114 Sec#147/203 |
| Cash | $17M | US#2,893/3,114 Sec#190/203 |
| Current Ratio | 4.55x | US#499/3,114 Sec#41/203 |
| Net Debt/EBITDA | 33.38x | US—/3,114 Sec—/203 |
| Performance | ||
| 1Y Return | 80.70% | US#658/3,114 Sec#55/203 |
| 1M Return | 37.32% | US#594/3,114 Sec#69/203 |
| From 52W High | -6.71% | US#606/3,114 Sec#57/203 |
| 1Y MDD | -27.20% | US#1,096/3,114 Sec#41/203 |
| Trading | ||
| Volume | 486,818 shares | US#2,121/3,114 Sec#144/203 |
| Trading Value | $15M | US#2,212/3,114 Sec#147/203 |
| Per Share | ||
| EPS | $-1.32 | US—/3,114 Sec—/203 |
| BPS | $13.21 | US#1,615/3,114 Sec#91/203 |
Company Info
OrthoPediatrics Corp. is a medical technology firm dedicated to the design, development, and global commercialization of specialized implants and devices. These products are meticulously crafted to be anatomically appropriate for treating children affected by orthopedic conditions across the United States and internationally. The company's diverse offerings span products for trauma and deformity correction, surgical systems for spinal deformities such as scoliosis, and solutions for sports medicine, among others. Their comprehensive product line features items like PediLoc, PediPlates, various cannulated screws, the PediFlex and PediNail systems, PediLoc tibia, advanced anterior cruciate ligament reconstruction systems, specialized locking cannulated blades and proximal femurs, Spica Tables, RESPONSE Spine systems, Bandloc, Pediguard, the Pediatric Nailing Platform, Femur system, Orthex, QuickPack, and the ApiFix Mid-C system. OrthoPediatrics Corp. primarily serves the pediatric orthopedic market, directly assisting pediatric orthopedic surgeons and caregivers. The company was founded in 2006 and maintains its headquarters in Warsaw, Indiana.